Pre-Operative Prediction of Advanced Prostatic Cancer Using Clinical Decision Support Systems: Accuracy Comparison between Support Vector Machine and Artificial Neural Network.
10.3348/kjr.2011.12.5.588
- Author:
Sang Youn KIM
1
;
Sung Kyoung MOON
;
Dae Chul JUNG
;
Sung Il HWANG
;
Chang Kyu SUNG
;
Jeong Yeon CHO
;
Seung Hyup KIM
;
Jiwon LEE
;
Hak Jong LEE
Author Information
1. Department of Radiology, Seoul National University College of Medicine, Seoul 110-744, Korea. hakjlee@snu.ac.kr
- Publication Type:Original Article ; Comparative Study
- Keywords:
Decision support systems, clinical;
Medical order entry systems;
Prostatic neoplasms;
Staging;
Needle biopsy
- MeSH:
Adult;
Aged;
Aged, 80 and over;
Area Under Curve;
Biopsy, Needle;
*Decision Support Systems, Clinical;
Humans;
Male;
Middle Aged;
*Neural Networks (Computer);
Prostate-Specific Antigen/blood;
Prostatectomy;
Prostatic Neoplasms/*diagnosis/pathology/surgery;
ROC Curve;
Sensitivity and Specificity;
*Support Vector Machines
- From:Korean Journal of Radiology
2011;12(5):588-594
- CountryRepublic of Korea
- Language:English
-
Abstract:
OBJECTIVE: The purpose of the current study was to develop support vector machine (SVM) and artificial neural network (ANN) models for the pre-operative prediction of advanced prostate cancer by using the parameters acquired from transrectal ultrasound (TRUS)-guided prostate biopsies, and to compare the accuracies between the two models. MATERIALS AND METHODS: Five hundred thirty-two consecutive patients who underwent prostate biopsies and prostatectomies for prostate cancer were divided into the training and test groups (n = 300 versus n = 232). From the data in the training group, two clinical decision support systems (CDSSs-[SVM and ANN]) were constructed with input (age, prostate specific antigen level, digital rectal examination, and five biopsy parameters) and output data (the probability for advanced prostate cancer [> pT3a]). From the data of the test group, the accuracy of output data was evaluated. The areas under the receiver operating characteristic (ROC) curve (AUC) were calculated to summarize the overall performances, and a comparison of the ROC curves was performed (p < 0.05). RESULTS: The AUC of SVM and ANN is 0.805 and 0.719, respectively (p = 0.020), in the pre-operative prediction of advanced prostate cancer. CONCLUSION: The performance of SVM is superior to ANN in the pre-operative prediction of advanced prostate cancer.
